Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Improves Endothelial Dysfunction in Association With Its Anti-Inflammatory Effects in Patients With Coronary Artery Disease and Uncontrolled Diabetes
Junichi Matsubara(Kumamoto University Hospital), Hisao Ogawa(Kumamoto University Hospital), Eiichiro Yamamoto(Kumamoto University), Seiji Hokimoto(Kumamoto University), Seigo Sugiyama(Diabetes Care Center), Koichi Kaikita(Kumamoto University), Koichiro Fujisue(Kumamoto University), Hirofumi Maeda(Kumamoto University), Hideaki Jinnouchi(Kumamoto University Hospital), Satomi Iwashita(Kumamoto University), Eiichi Akiyama(Kumamoto University), Hirofumi Kurokawa(Kumamoto University), Keisuke Ohba(Kumamoto University)
Cited by 199
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|753
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2015|449